Dr Zubin Bhagwagar

Zubin joined Rallybio in July 2018.  He is a physician-scientist with more than 25 years of academic and industry experience as a scientist, manager, and R&D leadership team member in the areas of biopharmaceuticals, small molecule therapeutics, and research technologies.  His expertise spans business development and drug development in both small molecules and biologics.

Prior to joining Rallybio, Zubin was VP External Innovation at Alexion Pharmaceuticals, Inc., where he was responsible for the organization, management and output of R&D diligence teams into various business development opportunities. Previously, he was Head of Global Strategic Evaluation in the Business Development Group of Alexion Pharmaceuticals, Inc., where he organized and led a team that screened more than 400 opportunities per year.  Prior to Alexion, Zubin held positions of increasing responsibility at Bristol-Myers Squibb, where he rose to the position of Head of the Clinical Pharmacology Medical Group.

Zubin received his medical degree from Delhi University and had subsequent training in psychiatry and neuroscience at the University of Oxford, where he was awarded a DPhil (PhD) in neuroimaging and neurobiology. He has extensive clinical training in neuroscience and has conducted clinical research in neuroscience/psychiatry at the Yale University School of Medicine, where he also holds a faculty appointment.